KV Pharma seeks Chapter 11 bankruptcy protection - Businessweek

08/06/12

KV Pharma seeks Chapter 11 bankruptcy protection
Businessweek
NEW YORK (AP) — K-V Pharmaceutical Co. has filed filing for Chapter 11 bankruptcy protection as it deals with weak sales, a payment related to its costly preterm birth drug Makena, and sanctions related to past manufacturing problems. The St. Louis ...
KV Pharmaceutical Files for Chapter 11Wall Street Journal

all 186 news articles »

[more]